Novel immunotherapy extends therapy now used in fighting leukemia, Israeli researchers say.

Engineered T cells could assassinate solid tumor cells

By ISRAEL21c —— Bio and Archives--October 21, 2019

Health and Medicine | Comments | Back To Full Article

*Tel Aviv University researchers, from left, Dr. Yaron Carmi, Diana Rasuluniriana and Dr. Peleg Ride.*

Immunotherapy is a promising cancer treatment that enhances the natural immune response. A new study led by Dr. Yaron Carmi of Tel Aviv University’s Sackler Faculty of Medicine finds that a form of immunotherapy — chimeric antigen receptors (CAR) T-cell therapy, used to treat the blood cancer leukemia– may work against other kinds of cancer as well.

Read Full Article...

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Commenting is not available in this channel entry.

Comments

Support Canada Free Press

Recommended by Canada Free Press